The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way from their copycat days to challenge Western dominance on innovation. https://www.japantimes.co.jp/business/2025/07/14/tech/china-biotech-world-drug-pipeline/?utm_medium=Social&utm_source=mastodon #business #tech #biotech #pharmaceuticals #china #medicine

U.S. President Donald Trump has vowed to push forward with his aggressive tariff regime, stressing he would not offer additional extensions on country-specific levies set to now hit in early August. https://www.japantimes.co.jp/business/2025/07/09/markets/trump-tariff-copper-drugs/?utm_medium=Social&utm_source=mastodon #business #markets #us #donaldtrump #trade #tariffs #republicans #copper #pharmaceuticals

Kobayashi Pharmaceutical remains only halfway through overhauling its corporate governance, as it struggles to restore public trust after health problems linked to some of its dietary supplements more than a year ago. https://www.japantimes.co.jp/business/2025/07/08/companies/kobayashi-reform-founding-family/?utm_medium=Social&utm_source=mastodon #business #companies #kobayashipharmaceutical #pharmaceuticals #corporategovernance #koji #health #norikazutoyoda

Drug wholesaler Medipal Holdings is seeking merger and acquisition opportunities to diversify its business and combat slower growth in the market in Japan. https://www.japantimes.co.jp/business/2025/07/01/companies/japan-medipal-drug-firm-ma/?utm_medium=Social&utm_source=mastodon #business #companies #medipalholdings #pharmaceuticals #acquisitions #mergers